Bexarotene: a promising anticancer agent
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Retinoids are biologically active derivatives of vitamin A, which play essential roles in embryonic or adult cell behavior modulating cell proliferation, differentiation and apoptosis. The biologic effects of retinoids are mediated by two distinct families of intracellular receptors: retinoid acid receptors (RARs)-α, -β and -γ and retinoid X receptors (RXR)-α, -β and -γ. Bexarotene is a selective RXR agonist, which exerts its effects in blocking cell cycle progression, inducing apoptosis and differentiation, preventing multidrug resistance, and inhibiting angiogenesis and metastasis, making it a promising chemopreventive agent against cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to its differentiating effect, it has also been reported to inhibit the proliferation of lymphoma and lung, liver and solid ovarian tumors [7,185,193].”
From Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity (2021) · cites this paper as [7]
In the citing paper
“Apart from the well-known indications in hypovitaminosis and skin diseases, retinoids have been successfully used in treating cancer”
From Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity (2021) · cites this paper as [7]
In the citing paper
“bexarotene can selectively bind to RXR and modulate gene expression and cell proliferation and has been successfully used in treating cutaneous T-cell lymphoma”
From Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity (2021) · cites this paper as [7]
Citations
Cites
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Tamm, I., Wang, Y., Sausville, E. A., Scudiero, D. A., Vigna, N. J., Oltersdorf, T., & Reed, J. C. (1998) · PubMed · Cited by 1,410
FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
Mann, B. S., Johnson, J. R., Cohen, M. H., Justice, R., & Pazdur, R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-10-1247 · Cited by 1,365 · cited 1×
“(Targretin/Ligand Pharmaceuticals) Launched: NSCLC, CTCL [ 11 ]”
Embryonic retinoic acid synthesis is essential for early mouse post-implantation development
Niederreither, K., Subbarayan, V., Dollé, P., & Chambon, P. (1999) · Nature Genetics · doi:10.1038/7788 · Cited by 1,077
Duvic, M., Hymes, K., Heald, P., Breneman, D., Martin, A. G., Myskowski, P., Crowley, C., Yocum, R. C., & for Members of the Bexarotene Worldwide Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.9.2456 · Cited by 706
Duvic, M. A., Martín, Á. G., Kim, Y. H., Olsen, E. A., Wood, G. S., Crowley, C., & Yocum, R. C. (2001) · PubMed · Cited by 499
Clinging to life: cell to matrix adhesion and cell survival
Reddig, P. J., & Juliano, R. L. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-5134-3 · Cited by 440
NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells
Bentires-Alj, M., Barbu, V., Fillet, M., Chariot, A., Relic, B., Jacobs, N., Gielen, J., Merville, M.-P., & Bours, V. (2003) · Oncogene · doi:10.1038/sj.onc.1206056 · Cited by 430
Retinoids in cancer chemoprevention
Lotan, R. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.9.8801164 · Cited by 423
Synthesis and Structure-Activity Relationships of Novel Retinoid X Receptor-Selective Retinoids
Boehm, M. F., Zhang, L., Badea, B. A., White, S. K., Mais, D. E., Berger, E., Suto, C. M., Goldman, M. E., & Heyman, R. A. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00044a014 · Cited by 370
Research works printed but not linked: 1
- Yocum RC, Miller VA, Warrell RP et al (2001) Long-term followup of patients with advanced non-small cell lung cancer treated with oral bexarotene. Proc Am Soc Clin Oncol 20:267
Cited by
Carazo, A., Macáková, K., Matoušová, K., Krčmová, L. K., Protti, M., & Mladěnka, P. (2021) · Nutrients · doi:10.3390/nu13051703 · Cited by 461
“In addition to its differentiating effect, it has also been reported to inhibit the proliferation of lymphoma and lung, liver and solid ovarian tumors [7,185,193].”
BackgroundRetinoid pathway and cancer therapeutics
Bushue, N., & Wan, Y.-J. Y. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.003 · Cited by 373
Drug repositioning: Progress and challenges in drug discovery for various diseases
Hua, Y., Dai, X., Xu, Y., Xing, G., Liu, H., Lu, T., Chen, Y., & Zhang, Y. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114239 · Cited by 232
“The mechanisms of anticancer are inhibition of cell cycle progression, inhibition of angiogenesis and metastasis [24].”
Retinoid X receptors in macrophage biology
Rőszer, T., Menéndez-Gutiérrez, M. P., Cedenilla, M., & Ricote, M. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.04.004 · Cited by 137
Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR
Hiebl, V., Ladurner, A., Latkolik, S., & Dirsch, V. M. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.03.003 · Cited by 134
Modulation of NRF2 signaling pathway by nuclear receptors: Implications for cancer
Namani, A., Li, Y., Wang, X. J., & Tang, X. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.05.003 · Cited by 126
Self-citationRetinoids as Chemo-Preventive and Molecular-Targeted Anti-Cancer Therapies
Hunsu, V. O., Facey, C. O. B., Fields, J. Z., & Boman, B. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147731 · Cited by 106
PPAR Agonists as Therapeutics for CNS Trauma and Neurological Diseases
Mandrekar-Colucci, S., Sauerbeck, A., Popovich, P. G., & McTigue, D. M. (2013) · ASN Neuro · doi:10.1042/an20130030 · Cited by 91
A review of the molecular design and biological activities of RXR agonists
de Almeida, N. R., & Conda‐Sheridan, M. (2019) · Medicinal Research Reviews · doi:10.1002/med.21578 · Cited by 88
Mehta, N., Wayne, A. S., Kim, Y. H., Hale, G. A., Alvarado, C. S., Myskowski, P. L., Jaffe, E. S., BUSAM, K. J., Pulitzer, M. P., Zwerner, J. P., et al. (2011) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2011.06.016 · Cited by 78
Daniel, B., Nagy, G., Horvath, A., Czimmerer, Z., Cuaranta-Monroy, I., Poliska, S., Hays, T. T., Sauer, S., Francois-Deleuze, J., & Nagy, L. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky157 · Cited by 73
Um, C., & Chemler, S. R. (2016) · Organic Letters · doi:10.1021/acs.orglett.6b01259 · Cited by 56
Vitamins and regulation of angiogenesis: [A, B1, B2, B3, B6, B9, B12, C, D, E, K]
Saghiri, M. A., Asatourian, A., Ershadifar, S., Moghadam, M. M., & Sheibani, N. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.09.005 · Cited by 56
Systematic review of combination therapies for mycosis fungoides
Humme, D., Nast, A., ERDMANN, R., Vandersee, S., & Beyer, M. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.06.005 · Cited by 54
Natural and synthetic retinoid X receptor ligands and their role in selected nuclear receptor action
Brtko, J., & Dvořák, Z. (2020) · Biochimie · doi:10.1016/j.biochi.2020.09.027 · Cited by 50
Lerner, V., Miodownik, C., Gibel, A., Sirota, P., Bush, I., Elliot, H., Benatov, R., & Ritsner, M. S. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m08160 · Cited by 45
Anticancer drugs repurposed for Alzheimer’s disease: a systematic review
Ancidoni, A., Bacigalupo, I., Remoli, G., Lacorte, E., Piscopo, P., Sarti, G., Corbo, M., Vanacore, N., & Canevelli, M. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00831-6 · Cited by 44
A comprehensive review on the role of Vitamin A on human health and nutrition
Beer, K., Singh, A., Ravi, S. C., Gupta, A., Kumar, A., & Sharma, M. M. (2024) · Journal of Environmental Biology · doi:10.22438/jeb/45/6/mrn-5339 · Cited by 43
Hacıoğlu, C., Kar, F., Kaçar, S., Şahıntürk, V., & Kanbak, G. (2021) · Medical Oncology · doi:10.1007/s12032-021-01476-z · Cited by 42
Natural Product Chemistry and Cancer Drug Discovery
Huryn, D. M., & Wipf, P. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-396521-9.00003-6 · Cited by 40
Rexinoid inhibits Nrf2-mediated transcription through retinoid X receptor alpha
Wu, J., Wang, H., & Tang, X. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.111 · Cited by 37
Self-citationSynopsis on the Linkage of Alzheimer's and Parkinson's Disease with Chronic Diseases
Jabir, N. R., Firoz, C. K., Baeesa, S. S., Ashraf, G. M., Akhtar, S., Kamal, W., Kamal, M. A., & Tabrez, S. S. M. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12344 · Cited by 35
Targeting truncated RXRα for cancer therapy
Zhang, X.-K., Zhou, H., & Su, Y. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv104 · Cited by 34
The novel function of bexarotene for neurological diseases
Liu, Y., Wang, P., Jin, G., Shi, P., Zhao, Y., Guo, J., Yin, Y., Shao, Q.-H., Li, P., & Yang, P. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102021 · Cited by 32
Cessation of Neoangiogenesis in Alzheimer's Disease Follows Amyloid-beta Immunization
Biron, K. E., Dickstein, D. L., Gopaul, R., Fenninger, F., & Jefferies, W. A. (2013) · Scientific Reports · doi:10.1038/srep01354 · Cited by 32
Leal, A. S., Zydeck, K., Carapellucci, S., Reich, L. A., Zhang, D., Moerland, J. A., Sporn, M. B., & Liby, K. T. (2019) · npj Breast Cancer · doi:10.1038/s41523-019-0135-5 · Cited by 32
Quereux, G., Saint-Jean, M., Peuvrel, L., Brocard, A., Knol, A., & Dréno, B. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.810718 · Cited by 32
Straus, D. J., Duvic, M. A., Horwitz, S. M., Hymes, K. B., Goy, A. H., Hernandez‐Ilizaliturri, F. J., Feldman, T. A., Wegner, B., & Myskowski, P. L. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt480 · Cited by 32
Zhu, J., Ning, R., Lin, X.-Y., Chai, D., Xu, C., Xie, H. B., Zeng, J.-Z., & Lin, J. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu017 · Cited by 31
Leal, A. S., Hung, P., Chowdhury, A. S., & Liby, K. T. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108561 · Cited by 30
Chen, L., Conda‐Sheridan, M., Reddy, P. V., Morrell, A. E., Park, E., Kondratyuk, T. P., Pezzuto, J. M., van Breemen, R. B., & Cushman, M. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3006806 · Cited by 30
Bauer, J. B., Lippert, W. P., Dorrich, S., Tebbe, D., Burschka, C., Christie, V. B., Tams, D. M., Henderson, A. P. D., Murray, B. A., Marder, T. B., et al. (2011) · ChemMedChem · doi:10.1002/cmdc.201100156 · Cited by 30
Triggering of Suicidal Erythrocyte Death by Bexarotene
Bhuyan, A. A. M., Bissinger, R., Cao, H., & Lang, F. J. W. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000453178 · Cited by 29
The relationship between thyroid disorders and vitamin A.: A narrative minireview
Capriello, S., Stramazzo, I., Bagaglini, M. F., Brusca, N., Virili, C., & Centanni, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.968215 · Cited by 28
Conda‐Sheridan, M., Park, E., Beck, D. E., Reddy, P. V., Nguyen, T. X., Hu, B., Lian, C., White, J. J., van Breemen, R. B., Pezzuto, J. M., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400026k · Cited by 28
Effects of RXR Agonists on Cell Proliferation/Apoptosis and ACTH Secretion/Pomc Expression
Saito‐Hakoda, A., Uruno, A., Yokoyama, A., Shimizu, K., Parvin, R., Kudo, M., Saito‐Ito, T., Sato, I., Kogure, N., Suzuki, D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141960 · Cited by 27
Morphology, in vivo distribution and antitumor activity of bexarotene nanocrystals in lung cancer
Wang, Y., Rong, J., Zhang, J., Liu, Y., Meng, X., Guo, H., Liu, H., & Chen, L. (2016) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2016.1225752 · Cited by 27
Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach
Advani, D., Gupta, R. V., Tripathi, R. S., Sharma, S., Ambasta, R. K., & Kumar, P. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104841 · Cited by 25
Osei-Sarfo, K., & Gudas, L. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215234 · Cited by 23
Simple and sensitive HPLC-UV method for determination of bexarotene in rat plasma
Lee, J. B., Zgair, A., Kim, T. H., Kim, M. G., Yoo, S. D., Fischer, P. M., & Gershkovich, P. (2016) · Journal of Chromatography B · doi:10.1016/j.jchromb.2016.11.024 · Cited by 22
Maestra, S. L., Micale, R. T., Flora, S. D., D’Agostini, F., Ganchev, G., Iltcheva, M., Petkov, N., Steele, V. E., & Balansky, R. M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs314 · Cited by 18
Leal, A. S., Moerland, J. A., Zhang, D., Carapellucci, S., Lockwood, B., Krieger-Burke, T., Aleiwi, B., Ellsworth, E. L., & Liby, K. T. (2021) · Cancers · doi:10.3390/cancers13195004 · Cited by 16
Effect of bexarotene on differentiation of glioblastoma multiforme compared with ATRA
Heo, J.-C., Jung, T.-H., Lee, S., Kim, H. Y., Choi, G., Jung, M., Jung, D., Lee, H. K., Lee, J.-O., Park, J.-H., et al. (2016) · Clinical & Experimental Metastasis · doi:10.1007/s10585-016-9786-x · Cited by 16
Gray, G. M., Ma, N., Wagner, C. E., & van der Vaart, A. (2017) · Journal of Molecular Modeling · doi:10.1007/s00894-017-3260-9 · Cited by 13
Suzuki, D., Saito‐Hakoda, A., Ito, R., Shimizu, K., Parvin, R., Shimada, H., Noro, E., Suzuki, S., Fujiwara, I., Kagechika, H., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181055 · Cited by 12
Heyman, B. M., & Beaven, A. (2018) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2018.07.283 · Cited by 12
Sami, N., & de la Feld, S. F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-61211-1.00046-2 · Cited by 11
Qi, Z., Fang, Y., He, Y., Liu, H., Fang, J., & Wan, Y. Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050013 · Cited by 11
Melatonin enhanced bexarotene efficacy in experimental mammary carcinogenesis
Orendáš, P., Kubatka, P., Kajo, K., Stollárová, N., Kassayová, M., Bojková, B., PEC, M., Nosáľ, V., Kisková, T., Žihlavniková, K., et al. (2012) · Neoplasma · doi:10.4149/neo_2012_060 · Cited by 10
Oncogenic and immunological values of RBM34 in osteosarcoma and its pan-cancer analysis.
Zhang, W., He, R. L., Cao, W., Li, D., Zheng, Q., & Zhang, Y. (2023) · PubMed Central · Cited by 10
Mani, R. J., Anand, M., Agarwal, K., Tiwari, A., Hashmi, Q. A. R., Singh, T. V., Nongdam, P., Katare, D. P., & Potshangbam, A. M. (2023) · Drugs and Drug Candidates · doi:10.3390/ddc2020013 · Cited by 8
Shah, P. V., & Rajput, S. (2018) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2018.1464467 · Cited by 7
Huang, Y., Gao, B., Jia, Y., Ma, H., Ma, W.-Y., Zhang, Y.-Q., & Lan, Y. (2024) · arXiv (Cornell University) · doi:10.48550/arxiv.2406.08961 · Cited by 7
Doxorubicin as a Drug Repurposing for Disruption of α-Chymotrypsinogen-A Aggregates
Ansari, N. K., Khan, H. S., & Naeem, A. (2024) · The Protein Journal · doi:10.1007/s10930-024-10217-w · Cited by 5
Sami, N. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-2003-7.00041-8 · Cited by 5
Nagaraju, K., Chowdary, Y. A., & Rao, M. V. B. (2021) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-020-00155-6 · Cited by 5
Avendaño, C., & Menéndez, J. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-62649-3.00015-6 · Cited by 4
The RXR Agonist MSU-42011 Reduces Tumor Burden in a Murine Preclinical NF1-Deficient Model
Hung, P., Moerland, J. A., Leal, A. S., Aleiwi, B., Ellsworth, E. L., Clapp, D. W., Staedtke, V., Bai, R.-Y., & Liby, K. T. (2025) · Cancers · doi:10.3390/cancers17121920 · Cited by 4
Khan, R., Dindar, Ç. K., Karayel, A., Silah, H., Kurnalı, S. Z., Haider, A., & Uslu, B. (2025) · ChemistrySelect · doi:10.1002/slct.202405000 · Cited by 4
Effect of Bexarotene on Platelet Activation and Apoptosis
Cao, H., Bissinger, R., Umbach, A. T., Gawaz, M., & Lang, F. J. W. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000478627 · Cited by 4
Avendaño, C., & Menéndez, J. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818549-0.00009-1 · Cited by 3
Subcutaneous Panniculitis-like T-cell Lymphoma: Review of Therapies
S, T. A. C., & Chaudhari, T. M. (2015) · Internal Medicine Open Access · doi:10.4172/2165-8048.1000198 · Cited by 3
Retinoid X Receptor Signalling in the Specification of Skeletal Muscle Lineage
Le, M., & Li, Q. (2012) · InTech eBooks · doi:10.5772/45879 · Cited by 2
Kannaiah, K. P., SHARMA, H. R., Chanduluru, H. K., Keshishian, R., & Obaydo, R. H. (2026) · Green Chemistry Letters and Reviews · doi:10.1080/17518253.2026.2706972 · Cited by 2
Ikawa, T., Yamazaki, E., Amagai, R., Kambayashi, Y., Sekine, M., Takahashi, T., Asano, Y., & Fujimura, T. (2025) · Cancers · doi:10.3390/cancers17020324 · Cited by 2
Cancer Chemopreventive Retinoids: Validation and Analysis of in Vivo and in Vitro Bioassay Results
Wille, J. J., Park, J. Y., & Shealy, Y. F. (2016) · Journal of Cancer Therapy · doi:10.4236/jct.2016.713098 · Cited by 2
Sun, M., Liu, Q., & Xu, A. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s557444 · Cited by 1
CHALLENGES AND OPPORTUNITIES WITH DRUG REPURPOSING: AN EMERGING TECHNIQUE IN DRUGS DISCOVERY
Harale, S., Hupare, P., Ghatage, P., Govande, V., Gurav, O., Bandgar, S. A., Patil, S. P., & Gaikwad, D. (2023) · INDIAN DRUGS · doi:10.53879/id.60.11.13058 · Cited by 1
Kumbhar, N., Aparna, M. A., Nimal, S. K., Shewale, P., Barale, S. S., & Gacche, R. N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15232-0.00021-7 · Cited by 1
Cutaneous T-Cell Lymphoma: Mycosis Fungoides and Sézary Syndrome
Voorhees, T. J., Bowers, E. V., Kelsey, C. R., Park, Y., & Beaven, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-25610-4_14 · Cited by 1
A Novel Case of Recalcitrant Juvenile Pityriasis Rubra Pilaris with Response to Bexarotene
Word, A. P., Patel, M., & Alan Menter, M. (2011) · Journal of Clinical & Experimental Dermatology Research · doi:10.4172/2155-9554.1000131 · Cited by 1
De, S. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-13312-1.00002-7
Conformational Fluctuations of Biomolecules Studied Using Molecular Dynamics and Enhanced Sampling
Gray, G. (2018) · Digital Commons - University of South Florida (University of South Florida)
Goodman, R. P. (2018) · Ulster University Research Portal (Ulster University)
Molecular and Chemical Modulation of NRF2 for Disease Intervention
Harder, B. G. (2017) · UA Campus Repository (The University of Arizona)
BindingDB (2013) · UC San Diego · doi:10.7270/q2qr4z7z
Role of the Retinoid X Receptors in Skeletal Muscle Development
May, M. L. (2011) · uO Research (University of Ottawa) · doi:10.20381/ruor-4626
Biological effects of retinoids against cancer
Jan, A., Jan, N., Sofi, S., & Mir, M. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-36516-4.00014-3
Çocukluk Çağında Vitamin ve Mineraller
Ersoy, M., İnal, G. A., Okuducu, U., Barutçu, S., Köşeci, B., Gündüz, N. T., Aydın, E., Haykır, N., Çelik, M. Y., Kekeç, İ., et al. (2025) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3548
Silva, H. C. B. (2016) · Americanae (AECID Library)
Al-Dawsari, N. A., Trotter, S. C., & Foss, F. M. (2013) · Wiley eBooks · doi:10.1002/9781118590638.ch20
Novel bexarotene esters - synthesis and spectroscopic characterization
Iliev, I., Agova, N., & Georgieva, S. F. (2025) · Analele Universităţii "Ovidius" Constanţa. Seria Chimie/"Ovidius" University Annals of Chemistry · doi:10.2478/auoc-2025-0016
Third generation of retinoids in the treatment of breast cancer
Mir, A. A., Masoodi, G., & Mir, M. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-36516-4.00021-0
Análogos de tiossemicarbazonas e 4-tiazolidinomas: síntese, Citotoxicidade e eficiência do ligante
BARBOSA, P. S. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Metadata
- Authors
- Qu, L., & Tang, X.
- Affiliations
- Zhejiang University (CN)
- Corresponding author
- Tang, Xiuwen
- ORCID
- Tang, Xiuwen
- Venue
- Cancer Chemotherapy and Pharmacology
- Published
- 2009-09-24
- Volume
- 65
- Issue
- 2
- Pages
- 201-205
- ISSN
- 0344-5704 (ISSN-L)
- 1432-0843
- OpenAlex
- W1988329373
- Cited by
- 78
- References
- 68
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 1 · 2023: 8 · 2022: 2 · 2021: 6 · 2020: 3 · 2019: 4 · 2018: 6 · 2017: 5 · 2016: 6 · 2015: 4 · 2014: 6 · 2013: 9 · 2012: 5
- FWCI
- 0.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cancer Chemotherapy and Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- bexarotene, retinoids, retinoid X receptor agonist, apoptosis, cell differentiation, cell cycle arrest, multidrug resistance, angiogenesis inhibition, metastasis, chemoprevention
- MeSH terms
- Bexarotene, Cell Cycle, Cell Differentiation, Humans, Neoplasm Metastasis, Tetrahydronaphthalenes, Anticarcinogenic Agents, Apoptosis, Drug Resistance, Neoplasm, Angiogenesis Inhibitors, Retinoid X Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.